logo
Do heart failure trials need an end point committee?
The role of the electrocardiogram as a prognostic tool in ST-segment elevation myocardial infarction
Dronedarone and vitamin K antagonists
Novel biomarkers in cardiovascular disease
Novel antiplatelet therapy
Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies
Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model
Electrocardiographic assessment for therapeutic proteins—scientific discussion
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation
Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease
International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences
Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial
Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction
Increase in tissue and circulating pentraxin3 levels in patients with aortic valve stenosis
Impact of prenatal diagnosis and anatomical subtype on outcome in double outlet right ventricle
Are changes in carotid intima-media thickness related to risk of nonfatal myocardial infarction? A critical review and meta-regression analysis
Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease
Association of ST2 levels with cardiac structure and function and mortality in outpatients
Longitudinal mechanics of the periinfarct zone and ventricular tachycardia inducibility in patients with chronic ischemic cardiomyopathy
Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy
Racial differences in long-term survival among patients with coronary artery disease
Impact of hospitalization on health-related quality of life in atrial fibrillation patients in Canada and the United States
Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia
Rapid adoption of drug-eluting stents
Serial angiographic findings and prognosis of stent fracture site without early restenosis after sirolimus-eluting stent implantation
Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure
Is screening cardiac inpatients for depression really feasible?
Is screening cardiac inpatients for depression really feasible?
Unified definition of clinical trials end points